Tags: Drug.

Sergliflozin etabonate (INN/USAN codenamed GW869682X) is an investigational anti-diabetic drug being developed by GlaxoSmithKline. It did not undergo further development after phase II.[citation needed]

Sergliflozin_etabonate_2.svg
ATC prefix
none
CAS number
408504-26-7
IUPAC name
2-(4-methoxybenzyl)phenyl 6-O-(ethoxycarbonyl)-β-(D)-glucopyranoside
PubChem
9824918

Loading...

This page contains content from the copyrighted Wikipedia article "Sergliflozin etabonate"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.